TY  - JOUR
AU  - Farmakis, Dimitrios
AU  - Agostoni, Piergiuseppe
AU  - Baholli, Loant
AU  - Bautin, Andrei
AU  - Comin-Colet, Josep
AU  - Crespo-Leiro, Maria G
AU  - Fedele, Francesco
AU  - García-Pinilla, Jose Manuel
AU  - Giannakoulas, George
AU  - Grigioni, Francesco
AU  - Gruchała, Marcin
AU  - Gustafsson, Finn
AU  - Harjola, Veli-Pekka
AU  - Hasin, Tal
AU  - Herpain, Antoine
AU  - Iliodromitis, Efstathios K
AU  - Karason, Kristjan
AU  - Kivikko, Matti
AU  - Liaudet, Lucas
AU  - Ljubas-Maček, Jana
AU  - Marini, Marco
AU  - Masip, Josep
AU  - Mebazaa, Alexandre
AU  - Nikolaou, Maria
AU  - Ostadal, Petr
AU  - Põder, Pentti
AU  - Pollesello, Piero
AU  - Polyzogopoulou, Eftihia
AU  - Pölzl, Gerhard
AU  - Tschope, Carsten
AU  - Varpula, Marjut
AU  - von Lewinski, Dirk
AU  - Vrtovec, Bojan
AU  - Yilmaz, Mehmet Birhan
AU  - Zima, Endre
AU  - Parissis, John
PY  - 2019
DO  - 10.1016/j.ijcard.2019.09.005
UR  - http://hdl.handle.net/10668/14822
T2  - International journal of cardiology
AB  - Inotropes aim at increasing cardiac output by enhancing cardiac contractility. They constitute the third pharmacological pillar in the treatment of patients with decompensated heart failure, the other two being diuretics and vasodilators. Three...
LA  - en
KW  - Acute heart failure
KW  - Advanced heart failure
KW  - Dobutamine
KW  - Inodilators
KW  - Inotropes
KW  - Levosimendan
KW  - Milrinone
KW  - Norepinephrine
KW  - Adrenergic beta-Agonists
KW  - Cardiotonic Agents
KW  - Consensus
KW  - Heart Failure
KW  - Humans
KW  - Patient Selection
KW  - Practice Patterns, Physicians'
TI  - A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus.
TY  - research article
VL  - 297
ER  -